Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Funny thing 2

<< Previous

Bullboard Posts

Next >>

Post by Mick00333on Mar 25, 2021 12:00pm

152 Views

Post# 32875571

Funny thing 2

I remember 2 days ago, there was around 7million buying share at 0.045 and now no one buying at 0.045 but at 0.04. Guys stop getting trolled if u want the price to grow up, stop trying to buy the lowest as possible cuz if you drop the price at 0.03 u wont be able to sell back your share at 0.04 that u try to buy now instead make the price grow so u can easily sell higher all the time.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario